Investor Releases

Date Title View
24 July, 2019 ICON Announces the Appointment of Ms. Julie O’Neill to Board of Directors and Confirms the Retirement of Professor Dermot Kelleher and Mr. Declan McKeon as Non-Executive Directors
24 July, 2019 ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
24 June, 2019 ICON and DIA Driving Insights to Action with DIA Live 2019
23 May, 2019 ICON’s Acquisition of MeDiNova Research
13 May, 2019 ICON Awarded Clinical Research Team of the Year and Best in Health Economics and Outcomes Research
09 May, 2019 ICON Launches New Patient Engagement Platform to Support Improved Patient Experience and Enrollment in Clinical Trials
01 May, 2019 ICON Reports First Quarter 2019 Results
05 March, 2019 ICON Wins Multiple Categories in 2019 CRO Leadership Awards
20 February, 2019 ICON Reports Fourth Quarter and Full Year 2018 Results
05 February, 2019 ICON Launches New Drug Safety Reporting Solution that Ensures Compliance through Automation
08 January, 2019 ICON Issues Financial Guidance for Full Year 2019
25 October, 2018 ICON Wins Pharma Contract Services Company of the Year at the Pharma Industry Awards 2018
24 October, 2018 ICON Reports Third Quarter 2018 Results
01 October, 2018 ICON Announces Release of ADDPLAN® neo
27 July, 2018 ICON Confirms Retirement of Co-Founder Dr. Ronan Lambe
25 July, 2018 ICON Reports Second Quarter 2018 Results
25 July, 2018 ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
27 June, 2018 ICON Is Collaborating with Practice Fusion, Inc. to Advance Health Research
11 June, 2018 ICON Enhances Endpoint Adjudication Services Using AG Mednet Advanced Technology
21 May, 2018 ICON launches FIRECREST Financial Disclosure to Reduce Administrative Costs and Increase Regulatory Compliance
Displaying 121 - 140 of 402


Search Investor